Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort.
V MontanoP LoprioreF GruossoV CarelliG P ComiM FilostoC LampertiT MonginiO MusumeciS ServideiP ToninA ToscanoG PrimianoM L ValentinoS BortolaniS MarchetG RicciA ModeneseS Cotti PiccinelliB RisiM MeneriI G ArenaG SicilianoMichelangelo MancusoPublished in: Journal of neurology (2022)
PMM patients showed a slow global decline valued by NMDAS at 12 months; 6MWT was a more reliable measurement below 408 m, substantially stable at 12 months. PEO patients had better motor performance and lower NMDAS than PEO&MiMy and MiMy also at 12 months of follow-up.